Successful implantation of CGuard carotid embolic system

241

InspireMD has announced that its new CGuard carotid embolic protection system has been successfully implanted in recent procedures, including a patient treated during the 17(th) Annual Symposium on Interventional Cardiology & Angiology held in Hamburg, Germany on 1 February 2014.

The proprietary CGuard carotid embolic protection system uses the same MicroNet technology featured on its MGuard and MGuard Prime coronary systems. The technology is a single-fibre knitted mesh wrapped on an open cell stent design in order to trap the debris that can travel downstream after a patient is treated with traditional stenting methods. This protects patients from plaque debris and blood clots breaking off and traveling distally in the arteries which can lead to life threatening strokes. The size, or aperture, of the MicroNet ‘pore’ is only 150–180 microns in order to maximise protection against plaque and thrombus.

 

“As a clinician who has successfully implanted the CGuard carotid embolic protection in multiple patients, I have experienced first-hand the life-saving applications it can have,” stated Joachim Schofer, from the Hamburg University Cardiovascular Center, in Hamburg, Germany. “The small pore size of the MicroNet technology allows excellent blood flow while trapping potentially harmful plaque debris and thrombus. The CGuard technology provides an elegantly simple solution for embolic protection for my carotid patients.”

 

The CGuard is CE marked and is currently being evaluated clinically in Europe.